covid
Buscar en
Angiología
Toda la web
Inicio Angiología Etiopatogenia de la aterosclerosis: de la importancia de la genética a la utili...
Información de la revista
Vol. 59. Núm. 2.
Páginas 103-109 (enero 2007)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 59. Núm. 2.
Páginas 103-109 (enero 2007)
Acceso a texto completo
Etiopatogenia de la aterosclerosis: de la importancia de la genética a la utilidad de la proteómica
Visitas
3947
A. López-Farré
Autor para correspondencia
lcarinv.hcsc@salud.madrid.org

Correspondencia: Unidad de Investigación Cardiovascular. Servicio de Cardiología. Instituto Cardiovascular. Hospital Clínico San Carlos. Profesor Martín Lagos, s/n. E-28040 Madrid.
, P.J. Mateos-Cáceres, C. Macaya
Unidad de Investigación Cardiovascular. Servicio de Cardiología. Instituto Cardiovascular. Hospital Clínico San Carlos. Madrid, España
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Wagner D.D..
New links between inflammation and thrombosis.
Arterioscler Thromb Vasc Biol., 25 (2005), pp. 1321-1324
[2.]
Libby P..
Inflammation in atherosclerosis.
Nature, 420 (2002), pp. 868-874
[3.]
Lusis A.J..
Atherosclerosis.
Nature, 407 (2000), pp. 233-241
[4.]
Emeson E.E., Robertson A.L. Jr.
T lymphocytes in aortic and coronary intimas: their potential role in atherogenesis.
Am J Pathol, 130 (1988), pp. 369-376
[5.]
Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K..
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.
Arteriosclerosis, 6 (1986), pp. 131-138
[6.]
Gaspardone A., Versaci F..
Coronary stenting and inflammation.
Am J Cardiol., 96 (2005), pp. 65-70
[7.]
L'Allier P.L., Tardif J.C., Gregoire J., Joyal M., Lesperance J., Fortier A., et al.
Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
Can J Cardiol., 21 (2005), pp. 495-500
[8.]
Pepper D.S..
Macromolecules released from platelet storage organelles.
Thromb Haemost, 42 (1980), pp. 1667
[9.]
Ashby B., Daniel J., Smith B..
Mechanisms of platelet activation and inhibition.
Hematol Oncol Clin N Am, 4 (1990), pp. 1-25
[10.]
Tan K.T., Watson S.P., Lip G.Y..
The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention.
Curr Med Chem Cardiovasc Hematol Agents, 2 (2004), pp. 169-178
[11.]
Molero L., Farré J., García-Méndez A., Jiménez Mateos-Cá-ceres P., Carrasco-Martín C., Millas I., et al.
Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pigs: role of glycoprotein IIb/IIIa receptors.
Cardiovasc Res, 57 (2003), pp. 109-118
[12.]
Gawaz M., Page S., Massberg S., Nothdurfter C., Weber M., Fisher C., et al.
Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation.
Thromb Haemost, 88 (2002), pp. 307-314
[13.]
Molero L., López-Farré A., Mateos-Cáceres P.J., Fernández-Sánchez R., Luisa-Maestro M., Silva J., et al.
Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery.
Br J Pharmacol, 146 (2005), pp. 419-424
[14.]
Mateos-Cáceres P.J., García-Méndez A., Farré J., Sánchez de Miguel L., Gómez J., De Andrés R., et al.
Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils.
Eur J Clin Invest, 32 (2002), pp. 895-900
[15.]
Nannizzi-Alaimo L., Alves V.L., Phillips D.R..
Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
Circulation, 107 (2003), pp. 1123-1128
[16.]
Weber A.A., Meila D., Jacobs C., Weber S., Kelm M., Strauer B.E., et al.
Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors.
Thromb Res, 106 (2002), pp. 25-29
[17.]
Loeys B.L., Schwarze U., Holm T., Callewaert B.L., Thomas G.H., Pannu H., et al.
Aneurysm syndromes caused by mutations in the TGF-beta receptor.
N Engl J Med., 355 (2006), pp. 788-798
[18.]
Balkestein E.J., Staessen J.A., Wang J.G., Van der Heijden-Spek J.J., Van Bortel L.M., Barlassina C., et al.
Carotid and femoral artery stiffness in relation to three candidate genes in a white population.
Hypertension, 38 (2001), pp. 1190-1197
[19.]
Staessen J.A., Wang J.G., Brand E., Barlassina C., Birkenhager W.H., Herrmann S.M., et al.
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.
J Hypertension, 19 (2001), pp. 1349-1358
[20.]
Hamanishi T., Furuta H., Kato H., Doi A., Tamai M., Shimomura H., et al.
Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients.
Diabetes, 53 (2004), pp. 2455-2460
[21.]
Wassef M., Upchurch G.R., Kuivaniemi H., Thompsom R.W..
Challenges and opportunities in abdominal aortic aneurysm research.
J Vasc Surg., 45 (2007), pp. 192-198
[22.]
Guo D., Hasham S., Kuang S.Q., Vaughan C.J., Boerwinkle E., Chen H., et al.
Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14.
Circulation, 103 (2001), pp. 2461-2468
[23.]
Neptune E.R., Frischmeyer P.A., Arking D.E., Myers L., Bunton T.E., Gayraud B., et al.
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.
Nat Genet, 33 (2003), pp. 407-411
[24.]
Anderson L., Seilhamer J..
A comparison of selected mRNA and protein abundances in human liver.
Electrophoresis, 18 (1997), pp. 533-537
[25.]
Gygi S.P., Rochon Y., Franza B.R., Aebersold R..
Correlation between protein and mRNA abundance in yeast.
Mol Cell Biol., 19 (1999), pp. 1720-1730
[26.]
Celis J.E., Bravo R..
Two-dimensional gel electrophoresis of proteins.
pp. 478
[27.]
Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., et al.
Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium.
Electrophoresis, 16 (1995), pp. 1090-1094
[28.]
Anderson N.G., Anderson N.L..
Twenty years of two-dimensional electrophoresis: past, present and future.
Electrophoresis, 17 (1996), pp. 443-453
[29.]
Mateos-Cáceres P.J., García-Méndez A., López-Farré A., Macaya C., Núñez A., Gómez J., et al.
Proteomic analysis of plasma from patients during an acute coronary syndrome.
J Am Coll Cardiol., 44 (2004), pp. 1578-1583
[30.]
Molero L., García-Méndez A., Alonso-Orgaz S., Carrasco C., Macaya C., López-Farré A..
Proteomic approach to identify changes in protein expression modified by 17β-oestradiol in bovine vascular smooth muscle cells.
Clin Sci, 109 (2005), pp. 457-463
[31.]
Marteau J.B., Zaiou M., Siest G., Visvikis-Siest S..
Genetic determinants of blood pressure regulation.
J Hypertens, 23 (2005), pp. 2127-2143
[32.]
Stebbing J., Srivastava P..
Heat shock protein-receptor-based pharmacogenomics: the search for new cancer antigens.
Pharmacogenomics, 8 (2007), pp. 117-120
[33.]
Alonso-Orgaz S., Moreno L., Macaya C., Rico L., Mateos-Cáceres P.J., Sacristán D., et al.
Proteomic study of plasma from moderate hypercholesterolemic patients.
J Proteome Res, 5 (2006), pp. 2301-2308
Copyright © 2007. SEACV
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos